Company intelligence / Profile preview

Mirabilis Medica

Bothell, Washington, United Statesfusfoundation.org ↗

Ownership: Private
Employees: ~3
Development stage: Commercial

Overview

Mirabilis Medica developed a non-invasive, high-resolution ultrasound device for the treatment of uterine fibroids. The technology was designed to localize and ablate fibroid tissue without surgery. As of 2017, the company was preparing for a pivotal US study and European commercial launch. The company's current status is inactive/dead.

Therapeutic areas: Women's Health
Modalities: Device (Non-invasive therapeutic ultrasound system)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Mirabilis Medica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mirabilis Medica.

Explore the full profile